top of page

News & Press


The breast cancer diagnosis technology – called PANProfiler – has been developed by Panakeia and can accurately predict biomarker status from digitally imaged routine pathology samples. The technology has received UKCA and CE certification for clinical use by health services in the UK and EU. Read more

bottom of page